Towards a new treatment for arterial thrombosis
Cardiovascular disease (CVD) is the leading cause of death in developed countries, surpassing cancer. Stroke, myocardial infarction or pulmonary embolism are due to thrombosis, i.e. blood clots that form inside blood vessels and thus, block the blood flow. Scientists from the University of Liège (GIGA), in collaboration with an American laboratory, may have discovered a novel anti-thrombotic strategy to prevent or treat these life threatening diseases. They have recently published their work in Circulation, the Journal of the American Heart Association (AHA) (1).
(1) Dual-specificity Phsophatase 3 Deficiency or Inhibition Limits Platelet Activation and Arterial Thrombosis.